These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32736940)

  • 21. Risk of intussusception after monovalent rotavirus vaccine (Rotavac) in Indian infants: A self-controlled case series analysis.
    INCLEN Intussusception Surveillance Network Study Group
    Vaccine; 2021 Jan; 39(1):78-84. PubMed ID: 32972735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rotavirus vaccination and short-term risk of adverse events in US infants.
    Layton JB; Butler AM; Panozzo CA; Brookhart MA
    Paediatr Perinat Epidemiol; 2018 Sep; 32(5):448-457. PubMed ID: 30048564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intussusception after Rotavirus Vaccine Introduction in India.
    Reddy SN; Nair NP; Tate JE; Thiyagarajan V; Giri S; Praharaj I; Mohan VR; Babji S; Gupte MD; Arora R; Bidari S; Senthamizh S; Mekala S; Goru KB; Reddy B; Pamu P; Gorthi RP; Badur M; Mohan V; Sathpathy S; Mohanty H; Dash M; Mohakud NK; Ray RK; Mohanty P; Gathwala G; Chawla S; Gupta M; Gupta R; Goyal S; Sharma P; Mathew MA; Jacob TJK; Sundaram B; Purushothaman GKC; Dorairaj P; Jagannatham M; Murugiah K; Boopathy H; Maniam R; Gurusamy R; Kumaravel S; Shenoy A; Jain H; Goswami JK; Wakhlu A; Gupta V; Vinayagamurthy G; Parashar UD; Kang G
    N Engl J Med; 2020 Nov; 383(20):1932-1940. PubMed ID: 33176083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rotavirus vaccination and intussusception: can we decrease temporally associated background cases of intussusception by restricting the vaccination schedule?
    Tai JH; Curns AT; Parashar UD; Bresee JS; Glass RI
    Pediatrics; 2006 Aug; 118(2):e258-64. PubMed ID: 16882770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Intussusception Following Pentavalent Rotavirus Vaccine (RotaTeq) Administration in 5 African Countries.
    Tate JE; Mwenda JM; Keita AM; Tapsoba TW; Ngendahayo E; Kouamé BD; Samateh AL; Aliabadi N; Sissoko S; Traore Y; Bayisenga J; Sounkere-Soro M; Jagne S; Burke RM; Onwuchekwa U; Ouattara M; Bikoroti JB; N'Zue K; Leshem E; Coulibaly O; Ouedraogo I; Uwimana J; Sow S; Parashar UD;
    Clin Infect Dis; 2024 Jan; 78(1):210-216. PubMed ID: 37596934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Cortese MM; Parashar UD;
    MMWR Recomm Rep; 2009 Feb; 58(RR-2):1-25. PubMed ID: 19194371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Addition of history of intussusception as a contraindication for rotavirus vaccination.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Oct; 60(41):1427. PubMed ID: 22012117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intussusception following rotavirus vaccination in the Valencia Region, Spain.
    Pérez-Vilar S; Díez-Domingo J; Puig-Barberà J; Gil-Prieto R; Romio S
    Hum Vaccin Immunother; 2015; 11(7):1848-52. PubMed ID: 26083707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential intussusception risk versus health benefits from rotavirus vaccination in Latin America.
    Desai R; Parashar UD; Lopman B; de Oliveira LH; Clark AD; Sanderson CF; Tate JE; Matus CR; Andrus JK; Patel MM
    Clin Infect Dis; 2012 May; 54(10):1397-405. PubMed ID: 22431803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia.
    Buttery JP; Danchin MH; Lee KJ; Carlin JB; McIntyre PB; Elliott EJ; Booy R; Bines JE;
    Vaccine; 2011 Apr; 29(16):3061-6. PubMed ID: 21316503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Rotavirus Vaccination With Inpatient and Emergency Department Visits Among Children Seeking Care for Acute Gastroenteritis, 2010-2016.
    Payne DC; Englund JA; Weinberg GA; Halasa NB; Boom JA; Staat MA; Selvarangan R; Azimi PH; Klein EJ; Szilagyi PG; Chappell J; Sahni LC; McNeal M; Harrison CJ; Moffatt ME; Johnston SH; Mijatovic-Rustempasic S; Esona MD; Tate JE; Curns AT; Wikswo ME; Sulemana I; Bowen MD; Parashar UD
    JAMA Netw Open; 2019 Sep; 2(9):e1912242. PubMed ID: 31560386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review of Over 15 Years Postmarketing Safety Surveillance Spontaneous Data for the Human Rotavirus Vaccine (Rotarix) on Intussusception.
    Singh T; Delannois F; Haguinet F; Molo LY
    Drug Saf; 2022 Feb; 45(2):155-168. PubMed ID: 35015268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No increased risk of intussusception after pentavalent rotavirus vaccination in China: a retrospective birth cohort using electronic health records of Ningbo city.
    Liu Z; Li N; Liu G; Xu L; Dong Y; Meng R; Yang Y; Zhan S
    Emerg Microbes Infect; 2023 Dec; 12(2):2270062. PubMed ID: 37815175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-marketing surveillance of intussusception after Rotarix administration in Afghanistan, 2018-2022.
    Anwari P; Burnett E; Chavers TP; Samsor A; Safi H; Safi N; Clark AD; Parashar UD; Tate JE
    Vaccine; 2024 Mar; 42(8):2059-2064. PubMed ID: 38413278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intussusception-related Hospitalizations Among Infants Before and After Private Market Licensure of Rotavirus Vaccines in Taiwan, 2001-2013.
    Yen C; Shih SM; Tate JE; Wu FT; Huang YC; Parashar UD; Hsiung CA
    Pediatr Infect Dis J; 2017 Oct; 36(10):e252-e257. PubMed ID: 28640005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of Intussusception after Monovalent Rotavirus Vaccination in Africa.
    Tate JE; Mwenda JM; Armah G; Jani B; Omore R; Ademe A; Mujuru H; Mpabalwani E; Ngwira B; Cortese MM; Mihigo R; Glover-Addy H; Mbaga M; Osawa F; Tadesse A; Mbuwayesango B; Simwaka J; Cunliffe N; Lopman BA; Weldegebriel G; Ansong D; Msuya D; Ogwel B; Karengera T; Manangazira P; Bvulani B; Yen C; Zawaira FR; Narh CT; Mboma L; Saula P; Teshager F; Getachew H; Moeti RM; Eweronu-Laryea C; Parashar UD;
    N Engl J Med; 2018 Apr; 378(16):1521-1528. PubMed ID: 29669224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity of RV1 and RV5 vaccines administered in standard and interchangeable mixed schedules: a randomized, double-blind, non-inferiority clinical trial in Mexican infants.
    Macías-Parra M; Vidal-Vázquez P; Reyna-Figueroa J; Rodríguez-Weber MÁ; Moreno-Macías H; Hernández-Benavides I; Fortes-Gutiérrez S; Richardson VL; Vázquez-Cárdenas P
    Front Public Health; 2024; 12():1356932. PubMed ID: 38463163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of intussusception after monovalent rotavirus vaccination.
    Weintraub ES; Baggs J; Duffy J; Vellozzi C; Belongia EA; Irving S; Klein NP; Glanz JM; Jacobsen SJ; Naleway A; Jackson LA; DeStefano F
    N Engl J Med; 2014 Feb; 370(6):513-9. PubMed ID: 24422678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of hospitalizations due to intussusception in Sicily in the pre-rotavirus vaccination era (2003-2012).
    Costantino C; Restivo V; Cuccia M; Furnari R; Amodio E; Vitale F
    Ital J Pediatr; 2015 Aug; 41():52. PubMed ID: 26232152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative schedules.
    Clark A; Tate J; Parashar U; Jit M; Hasso-Agopsowicz M; Henschke N; Lopman B; Van Zandvoort K; Pecenka C; Fine P; Sanderson C
    Lancet Glob Health; 2019 Nov; 7(11):e1541-e1552. PubMed ID: 31607466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.